Fairmount Funds Management as of Sept. 30, 2021
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 20 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 13.2 | $36M | 1.3M | 27.54 | |
| Zogenix Com New | 10.7 | $30M | 1.9M | 15.19 | |
| Nuvalent Inc-a (NUVL) | 7.5 | $21M | 915k | 22.55 | |
| Allakos (ALLK) | 6.8 | $19M | 175k | 105.87 | |
| Enanta Pharmaceuticals (ENTA) | 6.5 | $18M | 317k | 56.81 | |
| Argenx Se Sponsored Adr (ARGX) | 6.4 | $18M | 59k | 301.99 | |
| Trillium Therapeutics Com New | 5.7 | $16M | 886k | 17.56 | |
| Miragen Therapeutics (VRDN) | 5.6 | $16M | 944k | 16.45 | |
| Cogent Biosciences (COGT) | 4.8 | $13M | 1.6M | 8.41 | |
| Amarin Corp Spons Adr New (AMRN) | 4.7 | $13M | 2.5M | 5.10 | |
| Instil Bio | 4.4 | $12M | 674k | 17.87 | |
| Iovance Biotherapeutics (IOVA) | 3.5 | $9.6M | 390k | 24.66 | |
| Tyra Biosciences (TYRA) | 3.2 | $8.8M | 499k | 17.59 | |
| Point Biopharma Global | 3.1 | $8.5M | 1.1M | 7.69 | |
| Astria Therapeutics (ATXS) | 2.9 | $8.1M | 912k | 8.84 | |
| ACADIA Pharmaceuticals (ACAD) | 2.5 | $6.9M | 417k | 16.61 | |
| Global Blood Therapeutics In | 2.3 | $6.4M | 250k | 25.48 | |
| Axsome Therapeutics (AXSM) | 2.2 | $6.2M | 188k | 32.96 | |
| Keros Therapeutics (KROS) | 2.1 | $5.9M | 149k | 39.56 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.8 | $5.1M | 927k | 5.48 |
